Because of an increasing trend in the number of patients with VRE, and the potential impact on vancomycin susceptibility of C. difficile , the intervention was halted after a 5.5-month period.
← all excerpts
Use of primary oral vancomycin prophylaxis to stem an outbreak of <i>Clostridioides difficile</i> infection in intensive care patients.
1
—
—